Guidelines for Randomized Clinical Trial Critique and Rapid Appraisal
Guidelines for Randomized Clinical Trial Critique and Rapid Appraisal Assignment. The aim of the assignment is to demonstrate critical appraisal skills at the master’s level.
Guidelines for Randomized Clinical Trial Critique and Rapid Appraisal Assignment
The aim of the assignment is to demonstrate critical appraisal skills at the master’s level. Search the bibliographic databases and select a Randomized Clinical Trial that addresses your EBP problem.
Get approval of article to critique from the Professor. The suggested paper length is 3 pages, excluding title and reference pages.
You may use this critique in your EBP paper, Chapter 2 Review of Literature.
1. Read the full text article several times ( the link to the article I chose which the Professor approved is this https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214512/
2. Rapid Appraisal: Complete the Rapid Appraisal Critical Checklist of Randomized Clinical Trial in Appendix B in a word document and add notes.
3. Also, written Critique: Summarize the study by identifying the research elements in this order
(Authors, Year, Level Of Evidence, design, purpose, study variables, sampling, and measurement); then discuss your response to these 3 questions:
1. Firstly, are the results of the study valid?
2.Secondly, are the results reliable? and,
3.Will the results help me in caring for my patients ? (see Melnyk & Fineout-Overholt, Chapter 5).
This is a Quantitative assignment.
More Details:
Additionally, Ben A. Williams, PhD, came by his distrust of randomized controlled trials (RCTs) the hard way: He developed a kind of brain cancer with no proven treatment.
In conclusion, there had been randomized trials of various approaches, but they were all failures, says Williams, an emeritus psychology professor at the University of California at San Diego.
Lastly, and although several drugs had helped a small percentage of patients in Phase II trials, he says, it can be hard to get hold of therapies not yet vetted by Phase III trials.